RCVS
MCID: RVR002
MIFTS: 24

Reversible Cerebral Vasoconstriction Syndrome (RCVS) malady

Categories: Rare diseases, Neuronal diseases

Aliases & Classifications for Reversible Cerebral Vasoconstriction Syndrome

About this section
Sources:
31ICD10 via Orphanet, 48NIH Rare Diseases, 54Orphanet, 68UMLS
See all MalaCards sources

Aliases & Descriptions for Reversible Cerebral Vasoconstriction Syndrome:

Name: Reversible Cerebral Vasoconstriction Syndrome 48 54 68
 
Rcvs 48 54

Characteristics:

Orphanet epidemiological data:

54
reversible cerebral vasoconstriction syndrome:
Inheritance: Not applicable; Age of onset: Adult

Classifications:



External Ids:

Orphanet54 ORPHA284388
ICD10 via Orphanet31 I67.8

Summaries for Reversible Cerebral Vasoconstriction Syndrome

About this section
Wikipedia:71 Reversible cerebral vasoconstriction syndrome (RCVS, sometimes called Call-Fleming syndrome) is a... more...

MalaCards based summary: Reversible Cerebral Vasoconstriction Syndrome, also known as RCVS, is related to cerebritis and headache. Affiliated tissues include brain, endothelial and heart.

Related Diseases for Reversible Cerebral Vasoconstriction Syndrome

About this section

Graphical network of the top 20 diseases related to Reversible Cerebral Vasoconstriction Syndrome:



Diseases related to reversible cerebral vasoconstriction syndrome

Symptoms & Phenotypes for Reversible Cerebral Vasoconstriction Syndrome

About this section

Drugs & Therapeutics for Reversible Cerebral Vasoconstriction Syndrome

About this section

Drugs for Reversible Cerebral Vasoconstriction Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 15)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
NimodipineapprovedPhase 42566085-59-44497
Synonyms:
-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl-1-methylethyl Ester
1,4-Dihydro-2,6-dimethyl-4-(3&prime
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid
1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl 1-methylethyl ester
1-methylethyl 2-(methyloxy)ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-β-methoxyethyl ester 5-isopropyl ester
2-Methoxyethyl-1-methylethyl ester
2-methoxyethyl propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-methoxyethyl 1-methylethyl ester
3,5-pyridinecarboxylic acid 2-methoxyethyl 1-methylethyl ester
3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl), 2-methoxyethyl 1-methylethyl ester
3-(2-methoxyethyl) 5-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
3-O-(2-methoxyethyl) 5-O-propan-2-yl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-N,N-dimethyl-2,2-diphenyl-butanamide
66085-59-4
AB00513963
AC-11694
AC1L1IAS
AC1Q4G7S
Admon
Almirall Brand of Nimodipine
Alpharma Brand of Nimodipine
Andromaco Brand of Nimodipine
BAY e 9736
BPBio1_000876
BRD-A58048407-001-06-3
BRN 0459792
BSPBio_000796
BSPBio_001397
BSPBio_002412
Bay-E 9736
Bay-e-9736
Bayer Brand of Nimodipine
Bayvit Brand of Nimodipine
Bio-0178
Bio1_000118
Bio1_000607
Bio1_001096
Bio2_000117
Bio2_000597
Brainal
C07267
C21H26N2O7
CBiol_001832
CHEBI:160965
CHEBI:465248
CHEMBL1428
CHEMBL40792
CID4497
CPD000058300
Calnit
Cantabria Brand of Nimodipine
D00438
D009553
DB00393
DRG-0139
DivK1c_006812
EG-1961
EINECS 266-127-0
EU-0100891
Elan Brand of Nimodipine
Esteve Brand of Nimodipine
FT-0082761
HMS1361F19
HMS1570H18
HMS1791F19
HMS1922E04
HMS1989F19
HMS2052M05
HMS2089H13
HMS2093G11
Hexal Brand of Nimodipine
I06-0230
IDI1_033867
Isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
KBio1_001756
 
KBio2_000117
KBio2_002403
KBio2_002685
KBio2_004971
KBio2_005253
KBio2_007539
KBio3_000233
KBio3_000234
KBio3_001632
KBioGR_000117
KBioGR_001262
KBioSS_000117
KBioSS_002408
Kenesil
LS-131292
Lopac0_000891
MLS000069381
MLS000863294
MLS001076550
MLS002154061
MLS002172461
Modus
MolPort-001-840-190
N-149
N149_SIGMA
NCGC00015714-04
NCGC00015714-12
NCGC00024675-02
NCGC00024675-03
NCGC00024675-04
NCGC00024675-05
NCGC00024675-06
NCGC00024675-07
NCGC00024675-08
NCGC00024675-09
NIMOTOP (TN)
NimoGel
Nimodipin Hexal
Nimodipin ISIS
Nimodipin-ISIS
NimodipinISIS
Nimodipine (USAN/INN)
Nimodipine [USAN:BAN:INN]
Nimodipino
Nimodipino Bayvit
Nimodipino [INN-Spanish]
Nimodipinum
Nimodipinum [INN-Latin]
Nimotop
Nimotop(TM)
Nimotop, Nimodipine
Periplum
Periplum, Nimotop, BRN 0459792, DRG-0139
Prestwick0_000918
Prestwick1_000918
Prestwick2_000918
Prestwick3_000918
Remontal
S1747_Selleck
SAM001246890
SMR000058300
SPBio_001464
SPBio_002985
SPECTRUM1503600
STK642934
SpecPlus_000716
Spectrum2_001562
Spectrum3_000766
Spectrum4_000791
Spectrum5_001687
Spectrum_001880
UNII-57WA9QZ5WH
Vita Brand of Nimodipine
isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate
isopropyl 2-methoxyethyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate
nchembio.476-comp9
nchembio.79-comp6
nimodipine
2
VerapamilapprovedPhase 413052-53-92520
Synonyms:
(+-)-Verapamil
(+/-)-VERAPAMIL
(1)-3-(3,4-Dimethoxyphenyl)-6-((5,6-dimethoxyphenethyl)methylamino)hexane-3-carbonitrile
2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile
2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile
5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile
52-53-9
56949-77-0
AB00053495
AC-16016
AC1L1DV5
Akilen
Anpec
Apo-Verap
Arpamyl
Arpamyl LP
BPBio1_000268
BRD-A09533288-001-02-7
BRD-A09533288-003-05-6
BSPBio_000242
BSPBio_001513
BSPBio_002358
Berkatens
Bio-0754
Bio1_000425
Bio1_000914
Bio1_001403
Bio2_000233
Bio2_000713
C07188
C27H38N2O4
CCRIS 6749
CHEBI:9948
CHEMBL6966
CID2520
CP-16533-1
CP-165331
Calan
Calan SR
Calan sr
Calaptin
Calaptin 240 SR
Calcan
Cardiabeltin
Cardiagutt
Cardibeltin
Cardioprotect
Caveril
Civicor
Civicor Retard
Coraver
Cordilox
Cordilox SR
Corpamil
Covera-HS
Covera-Hs
Covera-hs
D-365
D02356
DB00661
Dexverapamil
Dignover
Dilacoran
Dilacoran HTA
DivK1c_000399
Drosteakard
Durasoptin
EINECS 200-145-1
EINECS 260-462-6
Elthon
FT-0080127
Falicard
Finoptin
Flamon
Geangin
HMS1791L15
HMS1989L15
HMS2089H17
Harteze
Hexasoptin
Hexasoptin Retard
Hormitol
I06-0063
IDI1_000399
IDI1_033983
Ikacor
Ikapress
Inselon
Iproveratril
Isoptimo
Isoptin
Isoptin Retard
Isoptin SR
Isoptin sr
Isoptine
Isoptino
Isotopin
Izoptin
Jenapamil
KBio1_000399
KBio2_000233
KBio2_002343
KBio2_002801
KBio2_004911
KBio2_005369
KBio2_007479
KBio3_000465
KBio3_000466
 
KBio3_002823
KBioGR_000233
KBioGR_001372
KBioGR_002343
KBioSS_000233
KBioSS_002346
L001330
LS-174
Lekoptin
Lodixal
Lopac0_001237
Magotiron
Manidon
Manidon Retard
MolPort-000-721-258
NCGC00016083-14
NCGC00024710-04
NCGC00024710-05
NCGC00024710-06
NCGC00024710-07
NCGC00024710-08
NCGC00024710-09
NCI60_020143
NINDS_000399
NSC272366
NU-Verap
Novapamyl LP
Novo-Veramil
Nu-Verap
Ormil
Praecicor
Prestwick0_000141
Prestwick1_000141
Prestwick2_000141
Prestwick3_000141
Quasar
Rapam
Robatelan
SPBio_001820
SPBio_002181
STK538085
Securon
Spectrum2_001740
Spectrum4_000906
Spectrum5_001786
Tarka
UNII-CJ0O37KU29
Univer
Univex
VERAPAMIL
Vasolan
Vasomil
Vasopten
Vera-Sanorania
Verabeta
Veracaps SR
Veracim
Veracor
Verahexal
Veraloc
Veramex
Veramil
Verapamil
Verapamil (USAN/INN)
Verapamil AL
Verapamil Acis
Verapamil Atid
Verapamil Basics
Verapamil Ebewe
Verapamil HCl
Verapamil Henning
Verapamil Injection
Verapamil MSD
Verapamil NM
Verapamil NM Pharma
Verapamil Nordic
Verapamil PB
Verapamil Riker
Verapamil SR
Verapamil Verla
Verapamil [USAN:BAN:INN]
Verapamil [USAN:INN:BAN]
Verapamil [Usan:Ban:Inn]
Verapamil-AbZ
Verapamilo
Verapamilo [INN-Spanish]
Verapamilum
Verapamilum [INN-Latin]
Verapin
Verapress 240 SR
Veraptin
Verasal
Verasifar
Veratensin
Verdilac
Verelan
Verelan PM
Verelan SR
Verexamil
Veroptinstada
Verpamil
Vetrimil
Vortac
Vérapamil
alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile
alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile
alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile
cMAP_000023
delta-365
nchembio.368-comp2
nchembio.79-comp5
3Anti-Arrhythmia AgentsPhase 43093
4Vasodilator AgentsPhase 43543
5Calcium, DietaryPhase 45713
6calcium channel blockersPhase 41985
7Antihypertensive AgentsPhase 44207
8
Glucosamineapproved, Nutraceutical1913416-24-8439213
Synonyms:
(+)-2-amino-2-deoxy-D-glucopyranose
(2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(2S,5R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
14257-69-3
2-Amino-2-deoxy-D-Glucose
2-Amino-2-deoxy-D-glucopyranose
2-Amino-2-deoxy-D-glucose
2-Amino-2-deoxy-beta-D-glucopyranose
2-Amino-2-deoxyglucose
2-Aminoglucose
2-Deoxy-2-amino-D-glucose
2-Deoxy-2-aminoglucose
2-amino-2-deoxy-D-glucopyranose
2-amino-2-deoxyglucose
2351-15-7
28905-10-4
2B4D44B2-D5AC-4DA4-9BE6-A4AE9574E4A6
3416-24-8
4-04-00-02017 (Beilstein Handbook Reference)
58-87-7
58267-75-7
6490-70-6
880765-44-6
90-77-7
911653-84-4
AC1L2D1C
AC1L96WB
AC1L9B8P
AC1Q4UBH
BRN 1724602
BSPBio_002086
C00329
C08349
CHEBI:28393
CHEBI:47977
CHEMBL234432
CID18897
CID439213
CID441477
CPD0-1193
Chitosamine
Cosamin
D-(+)-Glucosamine
 
D-Glucosamine
D-glucosamine
D04334
DB01296
DivK1c_000261
EINECS 222-311-2
GCS
Glucosamina
Glucosamina [INN-Spanish]
Glucosamine (USAN/INN)
Glucosamine [USAN:INN]
Glucosaminum
Glucosaminum [INN-Latin]
HMS500N03
HSDB 7469
IDI1_000261
InChI=1/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6-/m1/s1
KBio1_000261
KBio2_001311
KBio2_003879
KBio2_006447
KBio3_001306
KBioGR_000970
KBioSS_001311
LS-71671
MolPort-002-507-091
MolPort-003-944-937
NCGC00164421-01
NCGC00178826-01
NINDS_000261
SPBio_000477
STK801823
Spectrum2_000519
Spectrum3_000443
Spectrum4_000565
Spectrum5_000756
Spectrum_000831
Viartril-S
beta-D-Glucosamine
bmse000247
chitosamine
glucosamine
nchembio.189-comp4
nchembio.2007.41-comp7
nchembio.412-comp5
partially N-deacetylated poly-beta-1,6-N-acetyl-D-glucosamine
9Hypolipidemic Agents2785
10Lipid Regulating Agents2766
11Hypoglycemic Agents5896
12Anticoagulants2623
13Antimetabolites12054
14Fibrinolytic Agents2388
15Glucuronyl glucosamine glycan sulfate140

Interventional clinical trials:

idNameStatusNCT IDPhase
1RCVS: The Rational Approach to Diagnosis and TreatmentRecruitingNCT03150524Phase 4
2A Clinical Study of Fundus Findings in Toxaemia of PregnancyCompletedNCT03076619
3Prospective Observation for Serial Changes of Acute Intracranial Artery Dissection Using High Resolution MRIRecruitingNCT02914288
4Perfusion MRI in Reversible Cerebral Vasoconstriction SyndromeNot yet recruitingNCT02756416

Search NIH Clinical Center for Reversible Cerebral Vasoconstriction Syndrome

Genetic Tests for Reversible Cerebral Vasoconstriction Syndrome

About this section

Anatomical Context for Reversible Cerebral Vasoconstriction Syndrome

About this section

MalaCards organs/tissues related to Reversible Cerebral Vasoconstriction Syndrome:

36
Brain, Endothelial, Heart

Publications for Reversible Cerebral Vasoconstriction Syndrome

About this section

Articles related to Reversible Cerebral Vasoconstriction Syndrome:

(show top 50)    (show all 189)
idTitleAuthorsYear
1
Reversible Cerebral Vasoconstriction Syndrome during Chemotherapy for Acute Lymphoblastic Leukemia. (27769550)
2017
2
Reversible cerebral vasoconstriction syndrome and posterior reversible encephalopathy syndrome associated with intracranial hypotension. (27848124)
2017
3
Avoidance of steroids in the reversible cerebral vasoconstriction syndrome. (27940649)
2017
4
Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. (27940651)
2017
5
Diagnosing RCVS Without the CV: The Evolution of Reversible Cerebral Vasoconstriction Syndrome. (27366300)
2016
6
Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache. (27016378)
2016
7
Reversible cerebral vasoconstriction syndrome manifesting as focal seizures without a thunderclap headache: A pediatric case report. (27165442)
2016
8
Coexisting vascular lesions in reversible cerebral vasoconstriction syndrome. (26951336)
2016
9
Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: clinical, imaging, and angiographic comparison. (27043703)
2016
10
Reversible Cerebral Vasoconstriction Syndrome and Monoamine Oxidase Inhibitors. (27922229)
2016
11
Triptan-induced Reversible Cerebral Vasoconstriction Syndrome: Two Case Reports with a Literature Review. (27904122)
2016
12
Two rare neurologic complications after heart transplantation: Posterior reversible encephalopathy syndrome, followed by reversible cerebral vasoconstriction syndrome. (26987596)
2016
13
The Link Between Migraine, Reversible Cerebral Vasoconstriction Syndrome and Cervical Artery Dissection. (27016026)
2016
14
Transcranial Doppler Ultrasonography As a Non-Invasive Tool for Diagnosis and Monitoring of Reversible Cerebral Vasoconstriction Syndrome. (27579950)
2016
15
Reversible cerebral vasoconstriction syndrome. (27915588)
2016
16
Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome after bilateral carotid paraganglioma resection: A case report. (26873258)
2016
17
Reversible cerebral vasoconstriction syndrome presenting as subarachnoid hemorrhage: A rare cause of postpartum seizure. (27988255)
2016
18
Reversible Cerebral Vasoconstriction Syndrome. (27739275)
2016
19
Reversible cerebral vasoconstriction syndrome (RCVS) and headache attributed to aeroplane travel (AH): Does a link exist? (27919015)
2016
20
Cerebral vasomotor reactivity in reversible cerebral vasoconstriction syndrome. (27206962)
2016
21
The Typical Thunderclap Headache of Reversible Cerebral Vasoconstriction Syndrome and its Various Triggers. (27015869)
2016
22
Assessment of Noninvasive Regional Brain Oximetry in Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome. (26732768)
2016
23
Reversible cerebral vasoconstriction syndrome precipitated by airplane descent: Case report. (27521842)
2016
24
Reversible cerebral vasoconstriction syndrome (RCVS): a transient condition being underdiagnosed? (26951442)
2016
25
Reversible Cerebral Vasoconstriction Syndrome or Posterior Reversible Encephalopathy Syndrome-Reply. (26974693)
2016
26
Headache attributed to aeroplane travel and reversible cerebral vasoconstriction syndrome. (27811235)
2016
27
Reversible Cerebral Vasoconstriction Syndrome Promptly Diagnosed with Magnetic Resonance Imaging Including Magnetic Resonance Angiography During Immunosuppressive Therapy in a 16-Year-Old Girl with Refractory Cytopenia of Childhood. (27994838)
2016
28
Intravenous epoprostenol for treatment-refractory reversible cerebral vasoconstriction syndrome (RCVS). (27084217)
2016
29
The Need for a Rational Approach to Vasoconstrictive Syndromes: Transcranial Doppler and Calcium Channel Blockade in Reversible Cerebral Vasoconstriction Syndrome. (27721780)
2016
30
Reversible cerebral vasoconstriction syndrome is a rare cause of stroke after carotid endarterectomy. (26924717)
2016
31
Reversible Cerebral Vasoconstriction Syndrome vs Posterior Reversible Encephalopathy Syndrome. (26974597)
2016
32
Khat - a new precipitating factor for reversible cerebral vasoconstriction syndrome: a case report. (27978853)
2016
33
Reversible cerebral vasoconstriction syndrome presenting with severe headache and seizures. (26755022)
2016
34
Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis. (27012659)
2016
35
Severe reversible cerebral vasoconstriction syndrome after taking a product for slimming. (27481111)
2016
36
Reversible Cerebral Vasoconstriction Syndrome: A Report on Three Cases. (27455831)
2016
37
Reversible Cerebral Vasoconstriction Syndrome with Transient Splenial Lesions after Delivery. (27853083)
2016
38
Hemorrhagic Reversible Cerebral Vasoconstriction Syndrome: Features and Mechanisms. (27272485)
2016
39
Centripetal Propagation of Vasoconstriction at the Time of Headache Resolution in Patients with Reversible Cerebral Vasoconstriction Syndrome. (27079368)
2016
40
Magnesium for Treatment of Reversible Cerebral Vasoconstriction Syndrome: Case Series. (27366294)
2016
41
Herbal Supplements Association with Reversible Cerebral Vasoconstriction Syndrome: A Case Report. (28038897)
2016
42
Reversible cerebral vasoconstriction syndrome in association with fingolimod use. (27819760)
2016
43
Reversible Cerebral Vasoconstriction Syndrome Presenting With Visual Field Defects. (26807800)
2016
44
Marijuana induced Reversible Cerebral Vasoconstriction Syndrome. (25825630)
2015
45
Diffuse cerebrovascular dilation: Case report of amezinium metilsulfate-induced reversible cerebral vasoconstriction syndrome. (26016487)
2015
46
Recurrence of reversible cerebral vasoconstriction syndrome: A long-term follow-up study. (25788554)
2015
47
Reversible cerebral vasoconstriction syndrome at the emergency department. (27752599)
2015
48
Postpartum reversible cerebral vasoconstriction syndrome: Review and analysis of the current data. (25835347)
2015
49
Reversible Cerebral Vasoconstriction Syndrome and Posterior Reversible Encephalopathy Syndrome Presenting with Deep Intracerebral Hemorrhage in Young Women. (26523259)
2015
50
Meningitis and Reversible Cerebral Vasoconstriction Syndrome During the Postpartum Period. (26286264)
2015

Variations for Reversible Cerebral Vasoconstriction Syndrome

About this section

Expression for genes affiliated with Reversible Cerebral Vasoconstriction Syndrome

About this section
Search GEO for disease gene expression data for Reversible Cerebral Vasoconstriction Syndrome.

Pathways for genes affiliated with Reversible Cerebral Vasoconstriction Syndrome

About this section

GO Terms for genes affiliated with Reversible Cerebral Vasoconstriction Syndrome

About this section

Sources for Reversible Cerebral Vasoconstriction Syndrome

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet